SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS)
IONS 74.30+0.2%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: DSMIA6/8/2013 12:55:07 PM
   of 4676
 
Anyone still interested in ISIS? For example, what should an investor make of the recent secondary offering? Was the cash raised worth the dilution? Does it signal a shift away from the partnering/milestone strategy, reflect an effort to strengthen the company's hand in future negotiations, or something else entirely?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext